Ligthelm R - Search Results

1

Premixed insulin treatment for type 2 diabetes: analogue or human?

Garber AJ, Ligthelm R, Christiansen JS, Liebl A. Garber AJ, et al. Among authors: ligthelm r. Diabetes Obes Metab. 2007 Sep;9(5):630-9. doi: 10.1111/j.1463-1326.2006.00654.x. Diabetes Obes Metab. 2007. PMID: 17697056 Review.

2

Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.

Christiansen JS, Liebl A, Davidson JA, Ligthelm RJ, Halimi S. Christiansen JS, et al. Among authors: ligthelm rj. Diabetes Obes Metab. 2010 Feb;12(2):105-14. doi: 10.1111/j.1463-1326.2009.01144.x. Epub 2009 Nov 5. Diabetes Obes Metab. 2010. PMID: 19895637 Review.

3

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries.

Khunti K, Caputo S, Damci T, Dzida GJ, Ji Q, Kaiser M, Karnieli E, Liebl A, Ligthelm RJ, Nazeri A, Orozco-Beltran D, Pan C, Ross SA, Svendsen AL, Vora J, Yale JF, Meneghini LF; SOLVE Study Group. Khunti K, et al. Among authors: ligthelm rj. Diabetes Obes Metab. 2012 Dec;14(12):1129-36. doi: 10.1111/j.1463-1326.2012.01665.x. Epub 2012 Aug 30. Diabetes Obes Metab. 2012. PMID: 22830956

4

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.

Davidson JA, Liebl A, Christiansen JS, Fulcher G, Ligthelm RJ, Brown P, Gylvin T, Kawamori R. Davidson JA, et al. Among authors: ligthelm rj. Clin Ther. 2009 Aug;31(8):1641-51. doi: 10.1016/j.clinthera.2009.08.011. Clin Ther. 2009. PMID: 19808125

5

Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE).

Karnieli E, Baeres FM, Dzida G, Ji Q, Ligthelm R, Ross S, Svendsen AL, Yale JF; SOLVE Study Group. Karnieli E, et al. Among authors: ligthelm r. Drugs Aging. 2013 Mar;30(3):167-75. doi: 10.1007/s40266-013-0054-3. Drugs Aging. 2013. PMID: 23371395 Free PMC article.

6

Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.

Ligthelm RJ, Mouritzen U, Lynggaard H, Landin-Olsson M, Fox C, le Devehat C, Romero E, Liebl A. Ligthelm RJ, et al. Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):511-9. doi: 10.1055/s-2006-924424. Exp Clin Endocrinol Diabetes. 2006. PMID: 17115349 Clinical Trial.

7

Practical guidance to insulin management.

Meneghini L, Artola S, Caputo S, Damci T, Dzida G, Kaiser M, Khunti K, Liebl A, Ligthelm R, Maran A, Orozco-Beltran D, Ross S, Yale JF. Meneghini L, et al. Among authors: ligthelm r. Prim Care Diabetes. 2010 Apr;4 Suppl 1:S43-56. doi: 10.1016/S1751-9918(10)60008-3. Prim Care Diabetes. 2010. PMID: 20394891

8

Ten years of experience with biphasic insulin aspart 30: from drug development to the latest clinical findings.

Liebl A, Prusty V, Valensi P, Kawamori R, Christiansen JS, Palmer AJ, Balschmidt P, Ligthelm R, Mohan V. Liebl A, et al. Among authors: ligthelm r. Drugs. 2012 Jul 30;72(11):1495-520. doi: 10.2165/11635490-000000000-00000. Drugs. 2012. PMID: 22818015 Free PMC article. Review.

9

Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.

Clements MR, Tits J, Kinsley BT, Råstam J, Friberg HH, Ligthelm RJ. Clements MR, et al. Among authors: ligthelm rj. Diabetes Obes Metab. 2008 Mar;10(3):229-37. doi: 10.1111/j.1463-1326.2006.00687.x. Diabetes Obes Metab. 2008. PMID: 18269638 Clinical Trial.

10

Effect of baseline glycosylated hemoglobin A1c on glycemic control and diabetes management following initiation of once-daily insulin detemir in real-life clinical practice.

Caputo S, Andersen H, Kaiser M, Karnieli E, Meneghini LF, Svendsen AL; SOLVE Study Group. Caputo S, et al. Endocr Pract. 2013 May-Jun;19(3):462-70. doi: 10.4158/EP12269.OR. Endocr Pract. 2013. PMID: 23337147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51 results

Search Page